Free Trial

Surrozen (SRZNW) Competitors

$0.02 0.00 (-9.62%)
As of 05/2/2025

SRZNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Surrozen vs.

180 Life Sciences (NASDAQ:ATNFW) and Surrozen (NASDAQ:SRZNW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, community ranking, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

180 Life Sciences and Surrozen both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
SurrozenN/AN/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Surrozen. 180 Life Sciences' average media sentiment score of 0.59 beat Surrozen's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
Surrozen Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Surrozen$10.66MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Surrozen N/A N/A N/A

Summary

180 Life Sciences beats Surrozen on 2 of the 3 factors compared between the two stocks.

Get Surrozen News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRZNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRZNW vs. The Competition

MetricSurrozenBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$125.86M$5.54B$8.01B
Dividend YieldN/A3.69%5.37%4.22%
P/E RatioN/A3.2922.6018.87
Price / SalesN/A4,152.45399.33107.06
Price / CashN/A13.0238.1834.62
Price / BookN/A34.386.814.32
Net IncomeN/A-$90.45M$3.22B$247.98M
7 Day PerformanceN/A1.19%3.19%2.50%
1 Month PerformanceN/A8.11%11.90%13.16%
1 Year PerformanceN/A93.47%15.65%3.02%

Surrozen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRZNW
Surrozen
N/A$0.02
-9.6%
N/A-25.5%$0.00$10.66M0.0080Gap Down
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-14.1%$0.00N/A0.007Positive News
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.10
-5.9%
N/AN/A$0.00$20,729.000.0040Positive News
ALVOW
Alvotech
N/A$1.32
+3.1%
N/AN/A$0.00$489.68M0.004Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-20.5%
N/AN/A$0.00N/A0.0015Gap Down
BFRIW
Biofrontera
N/A$0.04
-13.1%
N/A-33.3%$0.00$37.32M0.0070Positive News
BTMDW
biote
N/A$0.02
-5.1%
N/A-81.4%$0.00$197.19M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.12
+8.0%
N/A-86.4%$0.00N/A0.008
CELUW
Celularity
N/A$0.04
-10.1%
N/AN/A$0.00$48.20M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:SRZNW) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners